Back to Agenda
S03 : Open Science accelerated by COVID-19, followed by Evidence Generation in the Era of Artificial Intelligence and Digital Transformation
Session Chair(s)
Tadashi Urashima, PhD
Performance and Digital Analytics Lead, Medical & Development Excellence Japan
GlaxoSmithKline K.K., Japan
Speaker(s)
Behind the Scenes of COVID-19 Clinical Practice Dealing with Emerging Infectious Diseases without Information
Toshibumi Taniguchi, MD, PhD
Chiba University Hospital, Japan
Ayano Hata
Shionogi & Co., Ltd, Japan
Shinsuke Muto
Integrity Healthcare Co., Ltd., Japan
Executive Chairman
Have an account?